CoChat

Long-term use of anti-cholesterol drugs and cancer risks in a Japanese population

Open access

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Several studies have investigated the association between the use of anti-cholesterol drugs and cancer risks, of which results have been inconsistent. This study included 67,768 participants from the Japan Public Health Center-based Prospective Study. The data on anti-cholesterol drug use was collected using three questionnaires of the survey conducted every five years. We divided the participants into three groups according to the duration of the anti-cholesterol drug use. Multivariable-adjusted Cox proportional hazard regression models were used to calculate hazard ratios (HR) and 95% confidence intervals (CI). During the 893,009 person-years of follow-up from the 10-year follow-up survey, 8,775 participants (5,387 men and 3,388 women) were newly diagnosed with cancers. The duration of anti-cholesterol drug use was significantly associated with a decreased risk of liver cancer (HR:0.26, 95% CI 0.11–0.64 in > 5 y group) and with an increased risk of pancreatic cancer (HR:1.59, 95% CI 1.03–2.47 in > 5 y group). Moreover, a different trend was observed between men and women in the association with the risk of lung cancer. This study suggested that long-term use of anti-cholesterol drugs may have associations with a decreased incidence of liver cancer and with an increased incidence of pancreatic cancers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-024-53252-4

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flowchart of study participants. The JPHC study enrolled 140,420 participants at the baseline. The exclusion criteria were applied and the final cohort for analysis consisted of 67,768 participants. Participants were divided into the following four categories (none, < 5 years, 5–10 years, and > 10 years) according to the duration of anti-cholesterol drug use up to the start of the follow-up period at which the 10-year follow-up survey was conducted. JPHC study, Japan Public Health Center-based Prospective Study.
Figure 1 Flowchart of study participants. The JPHC study enrolled 140,420 participants at the baseline. The exclusion criteria were applied and the final cohort for analysis consisted of 67,768 participants. Participants were divided into the following four categories (none, < 5 years, 5–10 years, and > 10 years) according to the duration of anti-cholesterol drug use up to the start of the follow-up period at which the 10-year follow-up survey was conducted. JPHC study, Japan Public Health Center-based Prospective Study.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 20

Metadata

Authors
Okita, Y., Sobue, T., Zha, L., Kitamura, T., Iwasaki, M., Inoue, M., Yamaji, T., Tsugane, S., & Sawada, N.
Affiliations
  • The University of Osaka (JP)
  • National Cancer Center Institute for Cancer Control (JP)
  • National Institute of Biomedical Innovation, Health and Nutrition (JP)
Corresponding author
Sobue, Tomotaka
Venue
Scientific Reports
Published
2024-02-05
Volume
14
Issue
1
Pages
2896-2896
ISSN
2045-2322 (ISSN-L)
OpenAlex
W4391536186
Cited by
14
References
31
Citations by year
2026: 5 · 2025: 5 · 2024: 4
FWCI
2.80
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan (19shi-2)
  • National Cancer Center Research and Development Fund (23-A-31(toku), 26-A-2, 29-A-4 and 2020-J-4)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
Keywords
statins, cancer risk, long-term drug use, duration of drug use, liver cancer, pancreatic cancer, lung cancer, sex differences, Japan Public Health Center-based Prospective Study
MeSH terms
Female, Humans, Japan, Liver Neoplasms, Male, Pancreatic Neoplasms, Prospective Studies, Risk Factors, Incidence, Proportional Hazards Models

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-term use of anti-cholesterol drugs and cancer risks in a Japanese population. https://app.cochat.ai/papers/10.1038/s41598-024-53252-4
The paper
Okita, Y., Sobue, T., Zha, L., Kitamura, T., Iwasaki, M., Inoue, M., Yamaji, T., Tsugane, S., & Sawada, N. (2024). Long-term use of anti-cholesterol drugs and cancer risks in a Japanese population. Scientific Reports. https://doi.org/10.1038/s41598-024-53252-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.